| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +10 K | 100% | $6.70 | +$67 K |
| Sells | 0 | ||||
| Net | +1 | +10 K | 100% | +$67 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James C. Clemmer | President and CEO, Director | $3.61 M | +$67 K | +1.89% | Apr 8, 2024 |
| Dennis S. Meteny | Director | $1.21 M | Jul 19, 2023 | ||
| Howard W. Donnelly | Director | $1.11 M | Jul 19, 2023 | ||
| Wesley Johnson | Director | $911 K | Jul 19, 2023 | ||
| Stephen A. Trowbridge | EVP and CFO | $602 K | Feb 29, 2024 | ||
| Jan Stern Reed | Director | $578 K | Jul 19, 2023 | ||
| Eileen O'Shea Auen | Director | $575 K | Jul 19, 2023 | ||
| Scott Centea | Svp/Gm, Vit | $503 K | Jul 20, 2023 | ||
| Karen A. Licitra | Director | $452 K | Jul 19, 2023 | ||
| Chad Thomas Campbell | SVP/GM, Vascular Access | $411 K | Jul 20, 2023 | ||
| Michael E. Tarnoff | Director | $391 K | Jul 19, 2023 | ||
| Warren Nighan JR | SVP Quality and Regulatory | $343 K | Jul 20, 2022 | ||
| Dave Helsel | SVP Global Operations and R&D | $245 K | Jul 20, 2023 | ||
| Laura Piccinini | SVP International | $165 K | Jul 20, 2023 | ||
| Lorinda Burgess | Director | $147 K | Jul 19, 2023 | ||
| Richard C. Rosenzweig | SVP and General Counsel | $136 K | Feb 1, 2023 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|